Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

869 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.
Ito Y, Nagasaki K, Miki Y, Iwase T, Akiyama F, Matsuura M, Horii R, Makita M, Tokudome N, Ushijima M, Yoshimoto M, Takahashi S, Noda T, Hatake K. Ito Y, et al. Among authors: iwase t. Cancer Sci. 2011 Jan;102(1):130-6. doi: 10.1111/j.1349-7006.2010.01740.x. Epub 2010 Sep 30. Cancer Sci. 2011. PMID: 20880335 Free PMC article. Clinical Trial.
[Breast cancer].
Sakai T, Iwase T. Sakai T, et al. Among authors: iwase t. Gan To Kagaku Ryoho. 2010 Dec;37(13):2829-32. Gan To Kagaku Ryoho. 2010. PMID: 21160258 Review. Japanese.
Prognostic value of matrix Gla protein in breast cancer.
Yoshimura K, Takeuchi K, Nagasaki K, Ogishima S, Tanaka H, Iwase T, Akiyama F, Kuroda Y, Miki Y. Yoshimura K, et al. Among authors: iwase t. Mol Med Rep. 2009 Jul-Aug;2(4):549-53. doi: 10.3892/mmr_00000135. Mol Med Rep. 2009. PMID: 21475864
Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
Ishitobi M, Ohsumi S, Inaji H, Ohno S, Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N, Takahashi K, Oura S. Ishitobi M, et al. Among authors: iwase t. Cancer. 2012 Sep 15;118(18):4385-93. doi: 10.1002/cncr.27377. Epub 2012 Jan 17. Cancer. 2012. PMID: 22252882 Free article.
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results.
Takahashi S, Iwase T, Kohno N, Ishikawa T, Taguchi T, Takahashi M, Horiguchi J, Nakamura S, Hozumi Y, Fukunaga M, Noguchi S. Takahashi S, et al. Among authors: iwase t. Breast Cancer Res Treat. 2012 Jun;133(2):685-93. doi: 10.1007/s10549-012-1973-0. Epub 2012 Feb 4. Breast Cancer Res Treat. 2012. PMID: 22307266 Clinical Trial.
869 results